Skip to main content
SpringerLink
Log in

Basal cell carcinoma

  • Chapter
European Handbook of Dermatological Treatments

  • 367 Accesses

Abstract

Basal cell carcinoma (BCC), is a slow-growing locally invasive epidermal tumour and metastases are extremely rare. BCC, the most common malignancy among Caucasians, is also known as basalioma, basal cell epithelioma, basal cell cancer, rodent ulcer, rodent cancer and non-Malpighian epithelioma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further reading

  • Bernardeau K, Derancourt C, Cambie M et al. Cryosurgery of basal cell carcinoma: a study of 358 patients. Ann Dermatol Venereol 2000; 127: 175–9.

    PubMed  CAS  Google Scholar 

  • Berridge JK, Morgan DA. A comparison of late cosmetic results following two different radiotherapy techniques for treating basal cell carcinoma. Clin Oncol (R Coll Radio!) 1997; 9: 400–2.

    Article  CAS  Google Scholar 

  • Beutner KR, Geisse JK, Heiman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999; 41: 1002–7.

    Article  PubMed  CAS  Google Scholar 

  • Buechner SA, Wernli M, Harr T, Hahn S, Itin P, Erb P. Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas) -CD95 ligand-induced suicide. J Clin Invest 1997; 100: 2691–6.

    Article  PubMed  CAS  Google Scholar 

  • Caccialanza M, Piccinno R, Beretta M, Gnecchi L. Results and side effects of dermatologic radiotherapy: a retrospective study of irradiated cutaneous epithelial neoplasms. J Am Acad Dermatol 1999; 41: 589–94.

    PubMed  CAS  Google Scholar 

  • Dogan B, Harmanyeri Y, Baloglu H, Oztek I. Intralesional alfa-2a interferon therapy for basal cell carcinoma. Cancer Lett 1995; 91: 215–19.

    Article  PubMed  CAS  Google Scholar 

  • Duvic M, Asano AT, Hager C, Mays S. The pathogenesis of psoriasis and the mechanism of action of tazarotene. J Am Acad Dermatol 1998; 39: S129 - S132.

    Article  PubMed  CAS  Google Scholar 

  • Griep C, Davelaar J, Scholten AN, Chin A, Leer JW. Electron beam therapy is not inferior to superficial X-ray therapy in the treatment of skin carcinoma. Int J Radiat Oncol Biol Phys 1995; 32: 1347–50.

    Article  PubMed  CAS  Google Scholar 

  • Ikic D, Padovan I, Pipic N et al. Interferon reduces recurrences of basal cell and squamous cell cancers. Int J Dermatol 1995; 34: 58–60.

    Article  PubMed  CAS  Google Scholar 

  • Johnson MR, Hageboutros A, Wang K, High L, Smith JB, Diasio RB. Life-threatening toxicity in a dihydropyrimidine dehydrogenasedeficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res 1999; 5: 2006–11.

    PubMed  CAS  Google Scholar 

  • Kagy MK, Amonette R. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg 2000; 26: 577–8.

    Article  PubMed  CAS  Google Scholar 

  • Kaplan B, Moy RL. Effect of perilesional injections of PEG-interleukin-2 on basal cell carcinoma. Dermatol Surg 2000; 26: 1037–40.

    Article  PubMed  CAS  Google Scholar 

  • Kuflike EG, Gage AA. The five year cure rate achieved by cryosurgery for cancer. J Am Acad Dermatol 1991; 24: 1002–4.

    Article  Google Scholar 

  • Levine N. Role of retinoids in skin cancer treatment and prevention. J Am Acad Dermatol 1998; 39: S62–6.

    Article  PubMed  CAS  Google Scholar 

  • Miller BH, Shavin JS, Cognetta A et al. Nonsurgical treatment of basal cell carcinomas with interlesional 5-fluorouracil/epinephrine infectable gel. JAm Acad Dermatol 1997; 36: 72–7.

    Article  CAS  Google Scholar 

  • Moeholt K, Aagaard H, Pfeiffer P, Hansen O. Platinum based cytotoxic therapy in basal cell carcinoma. Acta Oncol 1996; 35: 677–82.

    Article  PubMed  CAS  Google Scholar 

  • Peck GL, DiGiovanna JJ, Sarnoff DS et al. Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol 1988; 19: 176–85.

    Article  PubMed  CAS  Google Scholar 

  • Penis K, Fargnoli MC, Chimenti S. Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. N Pug! J Med 1999; 341: 1767–8.

    Article  Google Scholar 

  • Petit JY, Avril MF, Margulis A et al. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000; 105: 2544–51.

    Article  PubMed  CAS  Google Scholar 

  • Reymann F. Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study. Dermatologica 1979; 158: 368–72.

    Article  PubMed  CAS  Google Scholar 

  • Romagosa R, Saap L, Givens M et al. A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier. Dermatol Surg 2000; 26: 338–40.

    Article  PubMed  CAS  Google Scholar 

  • Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated primary basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315–28.

    PubMed  CAS  Google Scholar 

  • Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15: 424–31.

    PubMed  CAS  Google Scholar 

  • Sakata K, Aoki Y, Kumakura Yet al. Radiation therapy for patients with xeroderma pigmentosum. Radiat Med 1996; 14: 87–90.

    PubMed  CAS  Google Scholar 

  • Silverman MK, Kopf AW, Bart RS, Grin CM, Leven-stein MS. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol 1992; 18: 471–6.

    PubMed  CAS  Google Scholar 

  • Suhge d’Aubermont PC, Bennett RG. Failure of curettage and electrodesiccation for removal of basal cell carcinoma. Arch Dermatol 1984; 120: 1456–60.

    Article  PubMed  Google Scholar 

  • Thissen MR, Nieman FH, Ideler AH, Berretty PJ, Neumann HA. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 2000; 26: 759–64.

    Article  PubMed  CAS  Google Scholar 

  • Thissen MR, Schroeter CA, Neumann HA. Photo-dynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000; 142: 338–9.

    Article  PubMed  CAS  Google Scholar 

  • Wagner RF, Cottel WI. Multifocal recurrent basal cell carcinoma following primary tumour treatment by electrodesiccation and curettage. J Am Acad Dermatol 1987; 17: 1047–9.

    Article  PubMed  Google Scholar 

  • Weinstein GD, Krueger GG, Lowe NJ et al. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. Am Acad Dermatol 1997; 37: 85–92.

    Article  CAS  Google Scholar 

  • Wennberg AM, Lindholm LE, Alpsten M, Larkö O. Treatment of surperficial basal cell carcinomas using topically applied delta-aminolaevulinic acid and a filtered xenon lamp. Arch Dermatol Res 1996; 288: 561–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. D. Roseeuw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. D. Katsambas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. P. Hachem
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. ‘A. Sygros’ Hospital, Department of Dermatology, University of Athens, 5, I. Dragoumi Street, 161 21, Athens, Greece

    Andreas D. Katsambas

  2. University Unit Allergology Professional and Environmental Dermatology, University of Florence, Via Alfani 37, 50 121, Florence, Italy

    Torello M. Lotti

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Roseeuw, D., Katsambas, A.D., Hachem, J.P. (2003). Basal cell carcinoma. In: Katsambas, A.D., Lotti, T.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07131-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-07131-1_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-05657-4

  • Online ISBN: 978-3-662-07131-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation